1547041-34-8Relevant academic research and scientific papers
Heterocyclic compound and preparation method thereof
-
Paragraph 0454; 0455; 0456; 0457, (2018/11/03)
The invention discloses a compound shown in the formula (A), or a stereisomer thereof, or medically acceptable salt thereof, or a solvate thereof. The new compound shown in the formula (A) is good inURAT1 inhibitory activity and provides new medical possibilities for clinical treatment of diseases related to abnormal URAT1 activity.
BIARYL KINASE INHIBITORS
-
, (2017/07/31)
The present disclosure is directed to biaryl compounds of formula (I) which can inhibit AAKl (adaptor associated kinase 1), compositions comprising such compounds and their use for treating e.g. pain, Alzheimer's disease, Parkinson's disease and schizophrenia.
